What to Expect at the 2026 National Hematology Conference in Nashville

A National Hematology Conference That Goes Beyond CME

Amid a crowded roster of hematology conferences in 2026, the National Summit on Hematologic Cancers—a Nashville-based meeting taking place October 16 -17—stands out. The fall 2026 national hematology conference has all the hallmarks of a strong blood malignancies meeting: top hematology professionals and institutions, a cutting-edge program, the latest updates in the field of hematology, and, of course, a healthy dose of CME credits and ABIM MOC Points. But the most important takeaways from meetings like these are too easily lost when a conference becomes something to endure rather than engage with. To this end, the National Summit is designed differently. What exactly can you expect at this national hematology conference in Nashville?

Starting Where Guidelines End: The Gray Zone

The reality of hematology practice is this: clinical guidelines will only take you so far. The majority of treatment decisions happen in what the National Summit on Hematologic Cancers Planning Committee has termed the “Gray Zone”—that space of murky point-of-care uncertainty where guidelines are thin and optimal management is unclear. Can the hematologic malignancies Gray Zone be mapped out? The Summit is setting out to try. Through its highly interactive Gray Zone-based discussion model, clinician attendees will benefit from consensus statements and practical solutions. This aim has earned the Summit its 2026 theming: Defining the Standard Where the Guidelines End.

According to the conference website, “the goal is not to force artificial consensus, but to surface divergent expert perspectives, interrogate the evidence, and collectively work toward practical solutions that reflect real-world complexity in hematologic cancer care.”

Key Sessions Across Leukemia, Lymphoma, and Myeloma from Expert Faculty

Across high-grade lymphoma, frontline myeloma care, and controversy and clinical judgment in MDS/AML, the National Summit on Hematologic Cancers features key sessions across the spectrum of blood disorders. Important conversations and updates will be delivered by expert faculty—grounded, of course, in the ambitious project of the Gray Zone discussion model. Faculty come from some of the country's leading cancer programs, including Mayo Clinic, MD Anderson Cancer Center, and Fred Hutchinson Cancer Center, among others. Program-wise, expect MD Anderson’s Sattva Neelapu, MD, to speak on the future of CAR-T, drawing on his experience as principal investigator of the landmark ZUMA-1 trial. And stick around: Fred Hutch’s Jerald Radich, MD, will kick off day two of the conference with an MRD technology update.

$50K on the Line: Funding the Future of Hematology Research

Binaytara, the global oncology nonprofit organizing the Summit, is committing $250,000 toward the future of hematology research through the Shaji Kumar Hematology Research Awards, realized as multiple $50,000 and $25,000 grants. The awards are named for the Mayo Clinic myeloma specialist Shaji Kumar, MD—one of four co-chairs planning and shaping the Summit. The Shaji Kumar Hematology Research Awards will be presented to investigators whose work advances the understanding and treatment of hematologic cancers. Abstract submissions are open now, with a deadline of August 15, 2026.

The Summit carries multiple other publication and presentation opportunities: first authors of accepted abstracts will be invited to present orally or in a poster session, and consensus statements developed through the conference's Gray Zone discussions are published in the International Journal of Cancer Care and Delivery (IJCCD). giving the work a peer-reviewed home that extends well beyond the two days in Nashville.

Register for the 2026 National Hematology Conference in Nashville

The Summit is compact by design: two days, a focused program, and a format built around engagement rather than passive attendance. For hematologists, oncologists, and advanced practice providers looking to bring something useful back to clinic, it's worth the trip.

Register for the hematologic cancers summit before spots fill, and visit the 2026 national hematology conference page for the full program, faculty roster, and award details.